Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
---|
01/24/2008 | US20080020956 Transesterification composition of fatty acid esters, and uses thereof |
01/24/2008 | US20080020124 Producing Method of Phospholipids Including Long-Chain Polyunsaturated Fatty Acids as Constituents, and Use of Such Phospholipids |
01/24/2008 | US20080020056 Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease |
01/24/2008 | CA2658478A1 Synthetic lung surfactant and use thereof |
01/24/2008 | CA2657936A1 Antiviral protease inhibitors |
01/24/2008 | CA2657288A1 Phosphorus derivatives as histone deacetylase inhibitors |
01/23/2008 | EP1880736A1 Releasable linkage and composition containing same |
01/23/2008 | EP1879902A2 Methods for synthesis of carotenoids, including analogs, derivatives, and synthetic and biological intermediates |
01/23/2008 | EP1879860A2 1,4-diphenyl-3-hydroxyalkyl-2-azetidinone derivatives for treating hypercholestrolemia |
01/23/2008 | EP1725569B1 Prodrugs of piperazine and substituted piperidine antiviral agents |
01/23/2008 | EP1567468A4 A selective synthesis of organophosphites |
01/23/2008 | EP1418178B1 Flame retardant for polymeric materials |
01/23/2008 | CN101111505A 伊班膦酸盐多晶型物b Ibandronate polymorphs b |
01/23/2008 | CN101111504A 伊班膦酸盐多晶型物a Ibandronate a polymorph |
01/23/2008 | CN101111503A Method for producing phosphoric acid ester |
01/23/2008 | CN101111502A Tantalum compound, method for producing same, tantalum-containing thin film and method for forming same |
01/23/2008 | CN101108864A 9, 10- dihydro-9- oxa -10- phosphine hetero- phenanthrene -10- oxide compound and its derivant and method of preparing the same |
01/23/2008 | CN101108863A Method for preparing ether linkage, ester linkage hemolysis phosphoric acid ester |
01/23/2008 | CN101108861A Salts comprising cyanoborate anions |
01/23/2008 | CN101108822A Method of manufacturing glyphosate cogeneration paraquat |
01/23/2008 | CN101108759A Salts comprising cyanoborate anions |
01/23/2008 | CN100363370C Prosome compound water soluble salicylamide ammonium phosphate of CA4 and synthetic method |
01/23/2008 | CN100363369C Laminated organic-inorganic perofskite with metal defect inorganic frame |
01/23/2008 | CN100363319C Process for the hydroformylation of an ethylenically unsaturated compound using a bidentate diphosphine composition with a bridging group comprising sp2 hybridized carbon atoms bound to the phosphorou |
01/22/2008 | US7320997 Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease |
01/22/2008 | US7320993 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic useful as cytostatic and immuosuppressive agents |
01/22/2008 | CA2313319C Electrochemical synthesis of perfluoroalkylfluorophosphoranes |
01/22/2008 | CA2205136C Improved antiviral prodrugs of phosphonoacids |
01/17/2008 | WO2008008041A1 Phosphazene compound, lubricant and magnetic recording medium having such compound, method of preparation, and method of lubrication |
01/17/2008 | WO2008007579A1 Phosphorus molybdenum compound and method for producing the same |
01/17/2008 | WO2008007392A2 Process for the preparation of tenofovir |
01/17/2008 | WO2008006735A1 Method for producing organic phosphorous compounds containing halogene |
01/17/2008 | WO2008006454A1 Electroluminescent polymers and use thereof |
01/17/2008 | US20080015376 Catalytic hydrogenation processes |
01/17/2008 | US20080015352 zinc complexed with triiodothyronine; improved potency, stability, absorbability, targeted delivery |
01/17/2008 | US20080015195 Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase |
01/17/2008 | US20080015180 Methods and compositions for treating amyloid-related diseases |
01/17/2008 | US20080014253 Lipid-Based Drug Delivery Systems Containing Unnatural Phospholipase A2 Degradable Lipid Derivatives and the Therapeutic Uses Thereof |
01/17/2008 | CA2659121A1 Therapeutic compounds |
01/17/2008 | CA2657719A1 Cyclopentane derivatives as antiglaucoma agents |
01/17/2008 | CA2656805A1 Phosphorus molybdenum compound and method for producing same |
01/16/2008 | EP1878737A1 Method for producing indazole-3-ylmethylphosphonium salt |
01/16/2008 | EP1877414A2 Altering the crystal size distribution of n-(phosphonomethyl) iminodiacetic acid for improved filtration and product quality |
01/16/2008 | EP1877373A2 Biphenylazetidinone cholesterol absorption inhibitors |
01/16/2008 | EP1877372A1 Water-dispersible carotenoids, including analogs and derivatives |
01/16/2008 | EP1417209B1 High boiling inhibitors for distillable, polymerizable monomers |
01/16/2008 | EP1204626B1 Ether compounds, compositions, and uses thereof |
01/16/2008 | CN101104625A Liver targetable adefovir precursor medicament and medical use thereof |
01/16/2008 | CN101104587A 2-cyclohexenone compounds |
01/16/2008 | CN100362002C Method of oxidizing N-phosphonometyl to prepare glyphosate |
01/16/2008 | CN100362001C Polycondenseng phosphate and its preparation process and application thereof |
01/16/2008 | CN100361997C Salts comprising cyanoborate anions |
01/16/2008 | CN100361978C 2-pyrimidine oxy-N-aryl 7-nitrile or organic phosphate benzylamine compound, its production and use thereof |
01/16/2008 | CN100361966C Improved hydrocyanation process |
01/16/2008 | CN100361711C Diagnostic imaging contrast agents with extended blood retention |
01/15/2008 | US7319149 Chelants and macrocyclic metal complex radiopharmaceuticals thereof |
01/15/2008 | US7319107 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
01/15/2008 | US7319084 An addition polymerization catalyst of a cationic transition metal complex of a neutral bidentate ligand including a pyrole ring and an anion or nickelbis(1,5-cyclooctadiene), tri(pentafluorophenyl)borane and the neutral bidentate ligand; heat resistance; stability; steric hinderance for process control |
01/15/2008 | US7318966 Luminescent element material and luminescent element comprising the same |
01/15/2008 | CA2225943C Regenerated cellulose incorporating phosphorous compounds so as to be flame-retardant |
01/15/2008 | CA2132263C Liquid antioxidants as stabilisers |
01/10/2008 | WO2008005964A2 Phosphonate and phosphinate compounds as glucokinase activators |
01/10/2008 | WO2008005565A2 Antiviral phosphinate compounds |
01/10/2008 | WO2008005555A1 Modulators of toll-like receptor 7 |
01/10/2008 | WO2008005542A2 Antiviral phosphinate compounds |
01/10/2008 | WO2008005348A1 Synthesis of diethyl{ i5' (3 -fluorophenyl) -pyridine-2-yl] methyl} phosphonate used in the synthesis of himbacine analogs |
01/10/2008 | WO2008004000A1 Novel process for the preparation of bisphosphonic acids |
01/10/2008 | WO2008003809A1 Antitumour compounds |
01/10/2008 | WO2007125521A3 Polymorphic form of zoledronic acid and processes for their preparation |
01/10/2008 | US20080009639 Preparation of oseltamivir phosphate (Tamiflu) and intermediates starting from D-glucose or D-xylose |
01/10/2008 | US20080009637 Preparation of N-protected-3-pyrrolidine-lactam substituted phosphonium salts |
01/10/2008 | US20080009636 5-diethoxyphosphoryl-5-methyl-4-hydroxymethyl-1-pyrroline N-oxide; 5-diethoxyphosphoryl-4-(succinimidyloxycarbonyloxymethyl)-5-methyl-1-pyrroline-N-oxide |
01/10/2008 | US20080009630 Photogenerated reagents |
01/10/2008 | US20080009489 Androgen receptor modulators and method of treating disease using the same |
01/10/2008 | US20080009466 Crystalline forms of ibandronic acid and processes for preparation thereof |
01/10/2008 | US20080009465 Novel glucokinase activators and methods of using same |
01/10/2008 | US20080008874 Matrix-assisted laser desorption ionization mass spectrometry substrates having low volume matrix array elements |
01/10/2008 | DE102006028451A1 Verfahren zur Herstellung von N-Acyl-α-Aminonitrilen A process for preparing N-acyl-α-aminonitriles |
01/10/2008 | CA2658001A1 Novel glucokinase activators and methods of using same |
01/10/2008 | CA2656427A1 Modulators of toll-like receptor 7 |
01/10/2008 | CA2656356A1 Antiviral phosphinate compounds |
01/10/2008 | CA2656265A1 Synthesis of diethyl{ i5" (3 -fluorophenyl) -pyridine-2-yl] methyl} phosphonate used in the synthesis of himbacine analogs |
01/10/2008 | CA2656053A1 Novel process for the preparation of bisphosphonic acids |
01/09/2008 | EP1876182A1 Phosphine transition metal complex, process for producing the same and anticancer drug containing the same |
01/09/2008 | EP1876181A1 Ionic liquid containing phosphonium ion and method for producing same |
01/09/2008 | EP1874729A1 Biodegradable polyphosphazenes containing pyrrolidone side groups |
01/09/2008 | EP1685142B1 Phosphinic acid derivatives, beta-secretase inhibitors for the treatment of alzheimer's disease |
01/09/2008 | EP1434604A4 4-haloethenylphenyl tropane:serotonin transporter imaging agents |
01/09/2008 | CN101102769A Synthesis of sodium narcistatin and related compounds |
01/09/2008 | CN101100474A Fluoroquinolone compound containing phosphate ester group and its preparation method and use |
01/09/2008 | CN100360546C Process for one-pot preparation of chloromethyl monosodium phosphonate |
01/09/2008 | CN100360545C Organic phosphoramide hydrochloride |
01/09/2008 | CN100360544C Ammonium salt of cyclohexanpentol and its use |
01/09/2008 | CN100360543C Method for preparing ammonium salts of cyclohexanpentol phosphate ester |
01/09/2008 | CN100360496C Multidentate phosphite ligands, catalytic compositions containing such ligands and catalytic processes utilizing such catalytic compositions |
01/09/2008 | CN100360480C Amino group-containing chiral ionic liquid and its prepn process and application |
01/08/2008 | US7317131 Catalytic hydrogenation processes |
01/08/2008 | US7317129 Chemical synthesis of reagents for peptide coupling |
01/08/2008 | US7317120 Forming fire retardants; catalytic halogen free alkylation; simple, low cost |
01/08/2008 | US7317119 Process for the preparation of 9, 10-dihydro-9-OXA-10-organyloxyphosphaphenanthrene-10-oxide or -thione and derivatives of the same substituted on the phenyl groups |